BBIO
BridgeBio Pharma, Inc.NASDAQStock$66.88-0.67 (-0.99%)Mkt Cap 13.1BP/E —Div Yield —Beta 0.97Vol 992.8KAvg Vol 2.9M
52W$40.00
$79.91
ETFs That Hold BBIO (BridgeBio Pharma, Inc.)
1M
+1.01%
3M
-5.96%
6M
-11.75%
YTD
-14.62%
1Y
+62.37%
3Y
+330.41%
5Y
+6.93%
ETFs That Hold BBIO
BridgeBio Pharma, Inc. is held by 102 ETFs. The largest position by market value is in VB (Vanguard Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 6 of 6
Frequently Asked Questions
How many ETFs hold BBIO?
BridgeBio Pharma, Inc. (BBIO) is held by 102 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VB (Vanguard Small-Cap ETF).
What is the largest ETF that holds BBIO?
By fund size, VB (Vanguard Small-Cap ETF) with $177.40B in AUM holds 0.16% of its portfolio in BBIO, representing $285.8M in market value.
What percentage of HELX is BBIO?
BBIO makes up 3.56% of HELX (Franklin Genomic Advancements ETF), making it one of the largest positions in that fund.
Is BBIO in the S&P 500?
BBIO is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.